Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China

Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006-12: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone?

(2014) S. Jeverica et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Identification of Amino Acids Conferring High-Level Resistance to Expanded-Spectrum Cephalosporins in thepenAGene from Neisseria gonorrhoeae Strain H041

(2013) Joshua Tomberg et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates in Kyoto and Osaka, Japan, 2010 to 2012: Intensified Surveillance after Identification of the First Strain (H041) with High-Level Ceftriaxone Resistance

(2013) Ken Shimuta et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Global resistance of Neisseria gonorrhoeae

(2013) David A. Lewis   CURRENT OPINION IN INFECTIOUS DISEASES

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults

(2013) C Bignell et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada

(2013) Vanessa G. Allen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure

(2013) D. A. Lewis et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia

(2013) M. Y. Chen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia

(2013) Phillip J. Read et al.   Sexual Health

Prevalence and Molecular Epidemiological Typing of Penicillinase-Producing Neisseria gonorrhoeae and Their blaTEM-135 Gene Variants in Nanjing, China

(2013) Shao-Chun Chen et al.   SEXUALLY TRANSMITTED DISEASES

The use of cephalosporins for gonorrhea: an update on the rising problem of resistance

(2012) Juliet E Stoltey et al.   EXPERT OPINION ON PHARMACOTHERAPY

Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea

(2012) Magnus Unemo et al.   Future Microbiology

Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain

(2012) J. Camara et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Classical Sexually Transmitted Diseases Drive the Spread of HIV-1: Back to the Future

(2012) Myron S. Cohen   JOURNAL OF INFECTIOUS DISEASES

Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future

(2011) Magnus Unemo et al.   Annals of the New York Academy of Sciences

Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone

(2011) Makoto Ohnishi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: NovelpenAMosaic Allele in a Successful International Clone Causes Treatment Failure

(2011) Magnus Unemo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Review and International Recommendation of Methods for Typing Neisseria gonorrhoeae Isolates and Their Implications for Improved Knowledge of Gonococcal Epidemiology, Treatment, and Biology

(2011) M. Unemo et al.   CLINICAL MICROBIOLOGY REVIEWS

Analysis of mutations in multiple loci of Neisseria gonorrhoeae isolates reveals effects of PIB, PBP2 and MtrR on reduced susceptibility to ceftriaxone

(2011) M. Liao et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Gonococcal Resistance: Are Cephalosporins Next?

(2011) Robert D. Kirkcaldy et al.   Current Infectious Disease Reports

Characteristics and Dissemination of Mosaic Penicillin-Binding Protein 2-Harboring Multidrug-Resistant Neisseria gonorrhoeae Isolates with Reduced Cephalosporin Susceptibility in Northern Taiwan

(2010) C.-T. Huang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular and Structural Analysis of Mosaic Variants of Penicillin-Binding Protein 2 Conferring Decreased Susceptibility to Expanded-Spectrum Cephalosporins inNeisseria gonorrhoeae: Role of Epistatic Mutations

(2010) Joshua Tomberg et al.   BIOCHEMISTRY

Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2

(2010) D. M. Whiley et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone

(2010) S.-G. Lee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Genetics of Chromosomally Mediated Intermediate Resistance to Ceftriaxone and Cefixime in Neisseria gonorrhoeae

(2009) S. Zhao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characteristics and Population Dynamics of Mosaic penA Allele-Containing Neisseria gonorrhoeae Isolates Collected in Sydney, Australia, in 2007-2008

(2009) J. W. Tapsall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Meeting the public health challenge of multidrug- and extensively drug-resistantNeisseria gonorrhoeae

(2009) John W Tapsall et al.   Expert Review of Anti-Infective Therapy

Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes

(2009) M. Unemo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods

(2009) J. Tapsall et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci

(2009) J W Tapsall   SEXUALLY TRANSMITTED INFECTIONS